News Daily News Long-Awaited CREST-2 Results Bolster Stents for Asymptomatic Carotid Stenosis Todd Neale November 21, 2025
News Conference News AHA 2025 Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight Caitlin E. Cox November 18, 2025
News Conference News AHA 2025 Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD Todd Neale November 13, 2025
News Conference News AHA 2025 Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids Michael O'Riordan November 10, 2025
News Conference News AHA 2025 Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia Caitlin E. Cox November 08, 2025
News Conference News AHA 2025 Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV Michael O'Riordan November 08, 2025
News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025
News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
Presentation TCT 2025 TCT 496: Type 2 Diabetes Is Linked to More Severe Coronary Artery Disease on Cardiac Computed Tomography Angiography but Not to More Invasive Treatment: Insights from a Propensity-Matched Study Presenter: WIllem Robert van de Vijver October 28, 2025
Presentation TCT 2025 TCT 1003: Clinical Effectiveness of Glucagon-like peptide-1 receptor agonists on Cardiovascular outcomes Post-PCI in Type 2 Diabetes patients: Findings from the TriNetX Database Presenter: Aymen Ahmed October 27, 2025
Presentation TCT 2025 Multi-Organ Ethanol Denervation to Treat Type 2 Diabetes Mellitus and Hypertension: 6-Month Results of an Early Feasibility Study Presenter: Ajay J. Kirtane October 27, 2025
Presentation TCT 2025 TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database Presenter: Aymen Ahmed October 26, 2025
Presentation TCT 2025 TCT 775: Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database Presenter: Aymen Ahmed October 26, 2025
Presentation TCT 2025 TCT 208: Multi-Organ Arterial Denervation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities (NECTAR IV Trial) Presenter: Horst Sievert October 26, 2025
Presentation TCT 2025 TCT 748: Effects of SGLT2 Inhibitors on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus Undergoing Transcatheter Mitral Valve Repair: A Propensity-Matched Analysis Presenter: Mahmoud Abdelnabi October 25, 2025
Presentation TCT 2025 TCT 749: Renal Protective Effects of SGLT2 Inhibitors After Transcatheter Mitral Valve Repair in Patients with Type 2 Diabetes Mellitus: A Propensity-Matched Retrospective Analysis Presenter: Mahmoud Abdelnabi October 25, 2025
News Daily News Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Caitlin E. Cox October 22, 2025
News Opinion CV Team Dispatch September 2025 Dispatch for the CV Team L.A. McKeown September 30, 2025
News Daily News Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions L.A. McKeown September 22, 2025
News Daily News European Experts Provide Advice on Managing CV Effects of COVID-19 Todd Neale September 19, 2025